These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9409345)

  • 21. Fibrin D-dimer, tissue-type plasminogen activator, von Willebrand factor, and risk of incident stroke in older men.
    Wannamethee SG; Whincup PH; Lennon L; Rumley A; Lowe GD
    Stroke; 2012 May; 43(5):1206-11. PubMed ID: 22382157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
    Blann AD; Dobrotova M; Kubisz P; McCollum CN
    Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical role of von Willebrand factor in acute ischemic stroke.
    Menih M; Križmarić M; Hojs Fabjan T
    Wien Klin Wochenschr; 2017 Jul; 129(13-14):491-496. PubMed ID: 28409234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of population-based models of risk factors for TIA and ischemic stroke.
    Whisnant JP; Brown RD; Petty GW; O'Fallon WM; Sicks JD; Wiebers DO
    Neurology; 1999 Aug; 53(3):532-6. PubMed ID: 10449116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between vWF levels and aspirin resistance in ischemic stroke patients.
    Arslan Y; Yoldaş TK; Zorlu Y
    Transl Stroke Res; 2013 Oct; 4(5):484-7. PubMed ID: 24323374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemostatic variables in Pacific Islanders apparently free from stroke and ischaemic heart disease--the Kitava Study.
    Lindeberg S; Berntorp E; Carlsson R; Eliasson M; Marckmann P
    Thromb Haemost; 1997 Jan; 77(1):94-8. PubMed ID: 9031456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated tissue plasminogen activator antigen and stroke risk: The Stroke Prevention In Young Women Study.
    Macko RF; Kittner SJ; Epstein A; Cox DK; Wozniak MA; Wityk RJ; Stern BJ; Sloan MA; Sherwin R; Price TR; McCarter RJ; Johnson CJ; Earley CJ; Buchholz DW; Stolley PD
    Stroke; 1999 Jan; 30(1):7-11. PubMed ID: 9880380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum cholesterol and risk of ischemic stroke: results of a case-control study. On behalf of PROGETTO 3A Investigators.
    Di Mascio R; Marchioli R; Vitullo F; Di Pasquale A; Cavasinni L; Tognoni G
    Prev Med; 1995 Mar; 24(2):128-33. PubMed ID: 7597014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A study of plasma von Willebrand factor concentration in patients with cerebrovascular disease].
    Wang Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Apr; 25(2):106-8, 127. PubMed ID: 1499407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The post-stroke clotting battle: ADAMTS13 falls and puts out of control vWF into brain arteries.
    Montaner J
    J Neurol Sci; 2015 Jan; 348(1-2):1-2. PubMed ID: 25466693
    [No Abstract]   [Full Text] [Related]  

  • 31. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study.
    Rumley A; Lowe GD; Sweetnam PM; Yarnell JW; Ford RP
    Br J Haematol; 1999 Apr; 105(1):110-6. PubMed ID: 10233372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication.
    Nakano T; Irie K; Hayakawa K; Sano K; Nakamura Y; Tanaka M; Yamashita Y; Satho T; Fujioka M; Muroi C; Matsuo K; Ishikura H; Futagami K; Mishima K
    Brain Res; 2015 Oct; 1624():330-335. PubMed ID: 26254727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment.
    Gallego-Fabrega C; Temprano-Sagrera G; Cárcel-Márquez J; Muiño E; Cullell N; Lledós M; Llucià-Carol L; Martin-Campos JM; Sobrino T; Castillo J; Millán M; Muñoz-Narbona L; López-Cancio E; Ribó M; Alvarez-Sabin J; Jiménez-Conde J; Roquer J; Tur S; Obach V; Arenillas JF; Segura T; Serrano-Heras G; Marti-Fabregas J; Freijo-Guerrero M; Moniche F; Castellanos MDM; Morrison AC; Smith NL; de Vries PS; Fernández-Cadenas I; Sabater-Lleal M; ;
    J Thromb Haemost; 2024 Apr; 22(4):936-950. PubMed ID: 38103737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemostatic markers of endothelial injury in ischaemic stroke caused by large or small vessel disease].
    Iskra T; Turaj W; Słowik A; Zwolińska G; Strojny J; Szczudlik A
    Pol Merkur Lekarski; 2006 Nov; 21(125):429-33. PubMed ID: 17345834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of von Willebrand Factor, ADAMTS13, and Cerebral Artery Thrombus Composition in Patient Outcome Following Mechanical Thrombectomy for Acute Ischemic Stroke.
    Prochazka V; Jonszta T; Czerny D; Krajca J; Roubec M; Macak J; Kovar P; Kovarova P; Pulcer M; Zoubkova R; Lochman I; Svachova V; Pavliska L; Vrtkova A; Kasprak D; Gumulec J; Weisel JW
    Med Sci Monit; 2018 Jun; 24():3929-3945. PubMed ID: 29887594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait.
    Al-Awadhi A; Adekile A; Marouf R
    J Thromb Thrombolysis; 2017 Jan; 43(1):117-123. PubMed ID: 27613177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Von Willebrand factor and ADAMTS13 plasma in older patients with high CHA2DS2-VASc Score with and without atrial fibrillation.
    Zhang F; Yang XC; Jia XW; Tang XH; Wang Z; Wang ZQ
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4907-4912. PubMed ID: 29164570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinolytic gene polymorphism and ischemic stroke.
    Jood K; Ladenvall P; Tjärnlund-Wolf A; Ladenvall C; Andersson M; Nilsson S; Blomstrand C; Jern C
    Stroke; 2005 Oct; 36(10):2077-81. PubMed ID: 16179568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
    Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients.
    Bongers TN; de Bruijne EL; Dippel DW; de Jong AJ; Deckers JW; Poldermans D; de Maat MP; Leebeek FW
    Atherosclerosis; 2009 Nov; 207(1):250-4. PubMed ID: 19439298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.